toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
  Record Links
Author Hermansen, M.N.; Nielsen, K.G.; Buchvald, F.; Jespersen, J.J.; Bengtsson, T.; Bisgaard, H. url  doi
  Title Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma Type
  Year (down) 2006 Publication Chest Abbreviated Journal Chest  
  Volume 129 Issue 5 Pages 1203-1209  
  Keywords Administration, Inhalation; Adolescent; Adrenergic beta-Agonists/*administration & dosage/therapeutic use; Asthma/*drug therapy/etiology/physiopathology; Bronchoconstriction/*drug effects; Child; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Ethanolamines/*administration & dosage/therapeutic use; Exercise Test/adverse effects; Female; Follow-Up Studies; Forced Expiratory Volume/drug effects/physiology; Formoterol Fumarate; Humans; Male; Treatment Outcome  
  Abstract STUDY OBJECTIVE: To compare the acute bronchodilatory effect of the long-acting beta2-agonist formoterol against the short-acting beta2-agonist (SABA) terbutaline during exercise-induced bronchoconstriction (EIB) in children with asthma. DESIGN: A randomized, double-blind, placebo-controlled, crossover study of the immediate effect of formoterol, 9 microg, vs terbutaline, 0.5 mg, and placebo administered as dry powder at different study days. Exercise challenge test was used as a model of acute bronchoconstriction. PATIENTS: Twenty-four 7- to 15-year-old children with persistent asthma. INTERVENTIONS: The children performed standardized treadmill exercise tests, breathing dry air, with a submaximal workload. Study medication was administered 5 min after exercise if FEV1 dropped > or = 15% within 5 min after exercise. FEV1 and forced expiratory flows were measured repeatedly until 60 min after dose. RESULTS: Formoterol and terbutaline offered a significant acute bronchodilatory effect from 3 min after dose compared with placebo (p < 0.001). There was no difference between formoterol and terbutaline in FEV1 5 min after dose (p = 0.15), with a mean increase from each predrug baseline of 62% of the maximum increase for both. Median times to recovery within 5% of baseline FEV1 were 5.0 min and 7.4 min for formoterol and terbutaline, respectively (p = 0.33). CONCLUSION: Single-dose formoterol, 9 microg, via dry powder inhaler provided an acute bronchodilatory effect similar to terbutaline during EIB in schoolchildren with persistent asthma. Formoterol is at least as effective as SABA and may be considered an alternative in the treatment of acute bronchoconstriction in school children.  
  Address Department of Pediatrics, Copenhagen University Hospital, Gentofte, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark  
  Corporate Author Thesis  
  Impact Factor 07,483 First Author Hermansen, M.N. Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Senior Author Bisgaard, H.  
  ISSN 0012-3692 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:16685010 Approved no  
  Call Number Serial 193  
Permanent link to this record
Select All    Deselect All
 |   | 

Save Citations:
Export Records: